The Efficacy of Calcineurin Inhibitor Produced in the Russian Federation in Treatment of Patients With Atopic Dermatitis

Klinicheskaya Dermatologiya i Venerologiya - Russian Federation
doi 10.17116/klinderma20181705166
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Media Sphere Publishing Group

Related search

The Use of Topical Calcineurin Inhibitors in Atopic Dermatitis

Open Dermatology Journal
Dermatology
2014English

Future Trends in the Treatment of Atopic Dermatitis

Immunological Medicine
AllergyImmunology
2019English

Comparative Study of the Effectiveness of Antihistamine Preparations in the Treatment of Patients With Atopic Dermatitis

Zaporozhye Medical Journal
2019English

The Atopic Dermatitis Itch Scale: Development of a New Measure to Assess Pruritus in Patients With Atopic Dermatitis

Journal of Dermatological Treatment
Dermatology
2020English

Dupilumab for the Treatment of Atopic Dermatitis

Prescriber
Pharmacology
2018English

Effectiveness of Dupilumab Treatment in 95 Patients With Atopic Dermatitis: Daily Practice Data

British Journal of Dermatology
DermatologyMedicine
2019English

Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults

Oncotarget
Oncology
2017English

605 Efficacy and Safety of Dupilumab in Adolescent Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Structure and Function of the Epidermal Barrier in Patients With Atopic Dermatitis – Treatment Options. Part One

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy